MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Dopaminergic medication effect on speech in Parkinson’s disease: A kinematic study

    T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)

    Objective: To investigate the effect of levodopa on articulatory movement during Cantonese plosive production in individuals with Parkinson's disease (PD) by comparing kinematic parameters before…
  • 2016 International Congress

    A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson’s disease: The INVEST study

    D. van Poppelen, R.M.A. de Bie, J.M. Dijk (Amsterdam, Netherlands)

    Objective: To compare costs and effectiveness of the therapies DBS and CLI in advanced PD. Background: The therapies deep brain stimulation (DBS) and continuous intrajejunale…
  • 2016 International Congress

    The correlation between dietary fiber, fluid intake and constipation in patients with Parkinson’s disease

    N. Kawashima, A. Tabata, A. Kumon, K. Miyashita, A. Sato, H. Onuma, S. Nakamura, E. Horiuchi, K. Hasegawa (Fujisawa, Japan)

    Objective: To clarify the correlation between high dietary fiber, fluid intake and constipation in Parkinson's disease (PD) patients. Background: Constipation is one of the complications…
  • 2016 International Congress

    Engrailed enhances dopamine synthesis in healthy dopaminergic neurons

    D. Alvarez-Fischer, M. Baaske, F. Vulinovic, J. Fuchs, P. Seibler, A. Rakovic, A. Prochiantz, C. Klein (Lübeck, Germany)

    Objective: The aim of the present study was to further elucidate the role of Engrailed in dopamine neurotransmission. Background: Engrailed1 and Engrailed2, collectively Engrailed, are…
  • 2016 International Congress

    Tear fluid as potential biomarker for the diagnosis of Parkinson’s disease

    M. Börger, S. Funke, F. Maaß, A. Fischbach, M. Bähr, F. Grus, P. Lingor (Göttingen, Germany)

    Objective: This study compares tear fluid proteome in patients with idiopathic Parkinson´s disease (PD) and age-matched healthy controls (HC) to characterize disease-related proteomic changes and…
  • 2016 International Congress

    Supplement use in PD is associated with delayed initiation of dopaminergic therapy

    L. Chahine, S. Xie, K. Smith, C. Scordia, R. Purri, C. Linder, J. Duda, N. Dahodwala (Philadelphia, PA, USA)

    Objective: To describe supplement use among early PD patients, and to determine its association with time to initiation of dopamine replacement therapy (DRT). Background: Earlier…
  • 2016 International Congress

    Fighting Freezing of gait in Parkinson’s disease: Effect of a phase-dependent tactile biofeedback

    M. Mancini, K. Smulders, G. Harker, A.C. Fortaleza, J.G. Nutt, F.B. Horak (Portland, OR, USA)

    Objective: To investigate the effect of tactile biofeedback during every stance phase on freezing of gait (FoG) in Parkinson's disease (PD). Background: Accumulating evidence suggests…
  • 2016 International Congress

    Novel training based on declarative memory cues improves gait perfromance in patients with Parkinson’s disease: A randomized clinical trial

    M.E.P. Piemonte, E. Okamoto, K.R. Cardoso, T.P. Oliveira, C.S. Miranda, M. Pikel, F. Mendes, G.F. Xavier (Sao Paulo, Brazil)

    Objective: To verify the long-term efficiency of a new strategy based on declarative memory cues to improve the gait performance and independence in activities of…
  • 2016 International Congress

    Creativity related to dopaminergic treatment. A multicenter study

    P.J. Garcia Ruiz, J.C. Martinez Castrillo, L. Vela (Madrid, Spain)

    Objective: To study patients with Parkinson´s disease (PD) and enhanced creativity related to dopaminergic therapy. Background: Impulse control disorders (ICD) including pathological gambling, hypersexuality, and…
  • 2016 International Congress

    Dynamic prediction for multiple repeated measures and event time data: An application to Parkinson’s disease

    S. Luo, J. Wang (Houston, TX, USA)

    Objective: To develop methods for model-based personalized dynamic prediction of future outcome measure trajectories and risks of target events for the Parkinson's disease patients. Background:…
  • « Previous Page
  • 1
  • …
  • 1526
  • 1527
  • 1528
  • 1529
  • 1530
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley